ReviewJournal of neuroendocrinology2026
GLP-1 receptor agonists, metabolic syndrome, and Alzheimer's disease: Lessons and opportunities from the EVOKE trials.
Pragati Gupta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ReviewJournal of neuroendocrinology2026
Pragati Gupta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.